Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer (beta)
Based on guidelines from SUO and ASCO.
Strength
Strong recommendation
Moderate recommendation
Weak recommendation
Evidence
High quality evidence
Intermediate quality evidence
Low quality evidence
Insufficient evidence